RenovoRx, Inc. - Common Stock Share - Company Data & Prices - US75989R1077 | MoneyPeak

RenovoRx, Inc. - Common Stock

Share · US75989R1077 · RNXT (XNAS)

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

0

4

1

0

0

No Price

04.02.2026 22:02

Current Prices from RenovoRx, Inc. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	RNXT	USD	04.02.2026 22:02	0,96 USD	-0,05 USD -4,95 %

Share Float & Liquidity

Free Float 89,32 %

Shares Float 32,74 M

Shares Outstanding 36,65 M

Company Profile for RenovoRx, Inc. - Common Stock Share

RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.

AI Analysis of RenovoRx, Inc. - Common Stock

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of RenovoRx, Inc. - Common Stock

No AI threads available for this company yet.

Company Data

Name RenovoRx, Inc. - Common Stock

Company RenovoRx, Inc.

Symbol RNXT

Website https://renovorx.com

Primary Exchange

NASDAQ

ISIN US75989R1077

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Shaun R. Bagai

Market Capitalization 35 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 4546 El Camino Real, 94022 Mountain View

IPO Date 2021-08-26

Ticker Symbols

Name	Symbol
NASDAQ	RNXT

More Shares

Investors who hold RenovoRx, Inc. - Common Stock also have the following shares in their portfolio:

LAM RESEARCH CORP Share

TWD/USD US DOLLAR Currency

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2026